Texas Heart Institute Home
Continuing Medical Education
THI Home
for Program Director & Speaker
Resources for Physicians
For Commercial Supporters
Contact Us
View Site Map

Upcoming SymposiumSecond Annual
Symposium on

Risk, Diagnosis and Treatment of Cardiovascular Disease
in Women

October 1,  2011

8:30 a.m. – 5:00 p.m.

Denton A. Cooley Auditorium
Texas Heart Institute at
St. Luke's Episcopal Hospital
Houston, Texas 

Online registration is now closed. 
You may register at the event.     Symposium brochure

Program Overview

Cardiovascular disease (CVD) is the greatest threat to women's health worldwide, and the leading cause of death for women in the US. It affects more women than men, it kills more than 420,000 women annually and nearly 43 million American women live with some form of CVD. According to the U.S. Census Bureau, Texas has the third highest prevalence of heart disease in women—affecting more than 600,000 in 2004. CVD, also known as heart and vascular disease, includes heart attack, heart failure, stroke, peripheral artery disease and other diseases of the heart and circulatory system.

Most American women are unaware of their risk. Most doctors are too.

Women can expect to live a large part of their lives with an increased risk of CVD because their risk increases four-fold at menopause. One out of four American women older than 65 has some form of heart disease. Because heart attack symptoms can be very different in women than in men, women and the doctors who treat them are often unaware that a heart attack has occurred. Since treatment during or immediately after a heart attack significantly mitigates the resulting long-term damage, accurately identifying symptoms of heart attacks is critical to the lifetime wellness of women.

Just as symptoms differ between men and women, so may the effectiveness of treatments. Treatment guidelines are developed from the results of clinical trials published in the medical literature, dictating the standard of care for all patients. However, less than 25% of those enrolled in these trials are women. While effective treatments are not fully understood, we do know that women have 50% more adverse reactions to drugs than men, that controlling women's blood pressure reduces their risk more dramatically than men and that depression has double the negative impact on women than on men. What's more, the trajectory of women's heart disease is distinct from that of men. For example, plaque builds up differently in women's arteries, which typical testing does not detect. Finally, little study has gone into effective prevention strategies for women.  The goal of this symposium is to educate primary care physicians and cardiologists about diagnosis, treatment and prevention of heart disease in women.

Target Audience

Cardiologists, gynecologists, primary care physicians, Internal medicine physicians, family practice practitioners, endocrinologists and nurse practitioners.

Learning Objectives

At the conclusion of this conference, the participant should be able to:  

  • Cite the identification of cardiac risk factors in women;
  • Describe the trends and treatments of cardiovascular disease in obesity and sedentary lifestyles;
  • Review current guidelines for calcium supplementation and calcium scoring by computed tomography;
  • Identify emerging controversies in cardiovascular disease and treatments;
  • Make an overall cardiovascular risk stratification of female patients that will be used to guide prevention and treatment strategies.   

Program Schedule

Saturday October 1, 2011  

8:30 - 9:00 a.m.  Registration and Breakfast

8:45 - 9:00         Welcome and Opening Remarks
James T. Willerson, MD
                          President and Medical Director
                          THI at SLEH

9:00 - 9:20         Epidemiology of Coronary Artery Disease
                          and Cardiac Risk Factor
                        Stephanie Coulter, MD
                           Director, Center for Women's Heart & 
                           Vascular Health
                           THI at SLEH

9:20 - 9:40         Hypertension: Prevalence in Racial Groups,
                           Women's Increased Risks
                        Addison Taylor, MD, PhD
                           Professor of Medicine
                           Baylor College of Medicine

9:40 - 10:00       Dyslipidemia: Importance of Non HDL 
                          Cholesterol in 2011
                        Salim Virani, MD
                           Assistant Professor
                           Baylor College of Medicine  

10:00 - 10:20     Discussion

10:20 - 10:40     Break

10:40 - 11:00     Obesity and Sedentary Lifestyles Related to
                          Cardiovascular Disease in Women
                        Ann Barnes, MD
                          Assistant Professor of Medicine
                          Baylor College of Medicine            

11:00 - 11:20     Diabetes and Cardiovascular Disease:
                          What Have We Learned?
                        David Aguilar, MD
                          Assistant Professor of Medicine
                          Baylor College of Medicine

11:20 - 11:40     Depression and Coronary Heart Disease
                        Roberta C. Bogaev, MD, FACC, FACP
                          Medical Director, Heart Failure & Transplant
                          THI at SLEH 

11:40 - Noon      Discussion

Noon - 1:00 p.m. Lunch

1:00 -2:00 p.m.   Ethics Lecture: Inclusion of Women in 
                           Cardiovascular Research and its 
                           Importance for Women's Health
                        Anne Hamilton Dougherty, MD, FACC, 
                           FHRS, FAHA 
                           Professor of Medicine, 
                           Director, Cardiac Electrophysiology 
                           Co-Director, Advanced Cardiac
                           Arrhythmia Center 
                           Vice President, Human Research
                           The University of Texas Health Science 

2:00 - 2:20        Post-Menopausal Hormone Therapy
                       Stephanie Coulter, MD 

2:20 - 2:40        Cardiac Diseas in Pregnancy
                       Wilson Lam, MD
                          Texas Children's Hospital & THI at SLEH
                          Combined Adult-Pediatric Cardiology Fellow
                          Baylor College of Medicine

2:40 - 3:00        Discussion

3:00 - 3:20        Break  

3:20 - 3:40        Emerging Controversies in 
                          Cardiovascular Disease and Treatments
                       Stephanie Coulter, MD 

3:40 - 4:00        Coronary Revascularization in 2011
                          When should we do it and why?
                       Guilherme Silva, MD
                          Clinical Assistant Professor
                          Baylor College of Medicine
                          Assistant Medical Director, Stem Cell Center
                          THI at SLEH

4:00 - 4:20        TAVI: The Hype and the Hope
                       Blase Carabello, MD
                          Professor Medicine, Vice-Chairman, 
                          Department of Medicine, 
                          Baylor College of Medicine
                          Medical Care Line Executive,
                          Veterans Affairs Medical Center
                          Director, Center for Heart Valve Disease,
                          THI at SLEH

4:20 - 4:40       Discussion  

4:40                Adjourn

See the program brochure for further details. 

Texas Heart Institute at St. Luke's Episcopal Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Texas Heart Institute at St. Luke's Episcopal Hospital designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been designated by Texas Heart Institute for 1 hour of education in medical ethics and/or professional responsibility. 

An evaluation form sent via email will provide each participant the opportunity to review the speakers and their presentations, to identify educational needs, and to comment on any perceived commercial or promotional bias in the presentation.

Meeting Site and Lodging 

The symposium will be held at the Texas Heart Institute at St. Luke's Episcopal Hospital—The Denton A. Cooley Building located within the Texas Medical Center. The address is 6770 Bertner Avenue, Houston, Texas 77030. The meeting room, the Denton A. Cooley Auditorium is located on the B1 level of the hospital.


There are several hotels in the Texas Medical Center:

Marriott Medical Center
6580 Fannin Street Houston, Texas 77030
Phone:  713-796-0080

Hilton Houston Plaza
6633 Travis Street, Houston, Texas, 77030
Phone: 713-313-4000  

Holiday Inn Medical Center
6800 S. Main Street, Houston, Texas 77030
Phone: 713-528-7744

Cancellation Policy

All cancellations must be received in writing by Friday, September 23, 2011 in order for a refund to be issued. A $25 processing fee will be assessed for each cancellation. Refunds cannot be made for those who register but do not attend the scheduled activities. Texas Heart Institute reserves the right to cancel this activity if registration is deemed insufficient.

Registration fee includes all course materials, continental breakfast, lunch and refreshment breaks.

Category Registration Fee
Physicians (MD, DO) $75
Others* $50

* Fellows-in-training and residents (must provide a statement from their program directors regarding their status), students, nurse practitioners, and other allied health professionals.

Online registration is now closed. 
You may register at the event.     Symposium Brochure

Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.